Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kyphon Preparing IDE Submission For Spinal Bone Cement Filler, IPO

This article was originally published in The Gray Sheet

Executive Summary

Kyphon plans to submit an investigational device exemption application to FDA later this year for an acrylic bone cement filler material to treat spinal fractures

You may also be interested in...



Rhakoss Spinal Implant May Be Safer Alternative To Allograft – Orthovita

Orthovita is emphasizing its Rhakoss synthetic bone spinal implant as a potentially safer alternative to allograft for cervical spinal fusion surgery

Rhakoss Spinal Implant May Be Safer Alternative To Allograft – Orthovita

Orthovita is emphasizing its Rhakoss synthetic bone spinal implant as a potentially safer alternative to allograft for cervical spinal fusion surgery

Kyphon Seeking To Expand Applicability Of Spine Balloon To Wrist

Kyphon is hoping to expand its KyphX inflatable bone tamp platform technology beyond vertebral body compression fractures to include other compression fractures caused by osteoporosis in the wrist, knee and hip.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016221

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel